Ticalopride
Alternative Names: (+)-norcisapride; NorcisaprideLatest Information Update: 30 Apr 2002
At a glance
- Originator Sepracor
- Developer Janssen L.P.; Sepracor
- Class Antiulcers; Gastrokinetics
- Mechanism of Action Muscarinic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bulimia nervosa; Gastro-oesophageal reflux; Irritable bowel syndrome
Most Recent Events
- 30 Apr 2002 Discontinued - Phase-II for Gastro-oesophageal reflux in USA (PO)
- 30 Apr 2002 Discontinued - Preclinical for Bulimia nervosa in World (unspecified route)
- 30 Apr 2002 Discontinued - Preclinical for Irritable bowel syndrome in World (unspecified route)